摘要
新辅助放化疗是局部晚期可手术食管鳞癌的首选治疗模式,若能在治疗前或治疗中准确鉴别出可获益的患者,对于整体治疗策略的制定有重要意义。全文从影像学、超声胃镜、肿瘤标志物、临床指标对食管鳞癌新辅助放化疗疗效预测方面的研究进展做一综述。
Neoadjuvant chemoradiotherapy is the preferred treatment mode for locally advanced operable esophageal squamous cell carcinoma.If the possibly benefited patients can be identified before or during treatment,it is of great significance for the formulation of overall treatment strategy.This paper reviews the research progress on efficacy predicting of neoadjuvant chemoradiotherapy for esophageal squamous cell carcinoma with application of imaging,endoscopy,ultrasonography,tumor markers and clinical indicators.
作者
巩合义
伊艳
张健
李宝生
GONG Heyi;YI Yan;ZHANG Jian;LI Baosheng(Affiliated Central Hospital of Shandong First Medical University,Jinan 250012,China;Cancer Hospital Affiliated to Shandong First Medical University,Shandong Provincial Key Laboratory of Radiation Oncology,Shandong Cancer Institute,Jinan 250117,China;Cancer Hospital of Tianjin Medical University,National Cancer Clinical Medicine Research Center,Tianjin Municipal Key Laboratory of Cancer Prevention and Treatment,Tianjin Cancer Clinical Medicine Research Center,Tianjin 300060,China)
出处
《中国肿瘤》
CAS
CSCD
北大核心
2024年第8期668-675,共8页
China Cancer
基金
山东省自然科学基金(ZR2022ZD31)
山东第一医科大学学术提升计划(2019LJ004)。
关键词
食管肿瘤
新辅助放化疗法
疗效预测
影像学
超声胃镜
肿瘤标志物
esophageal neoplasms
neoadjuvant radiochemotherapy
response prediction
imaging
endoscopic ultrasonography
tumor marker
